The size of the Asia-Pacific Sleep Aids Market was worth USD 11.18 billion in 2020 and is estimated to be growing at a CAGR of 6.9%, to reach USD 15.61 billion by 2025.
The market is expected to show evident potential in the mentioned forecast period. The market is growing due to the rising geriatric population and increasing awareness among various organizations about sleep disorders. With the increase in the number of professionals working night shifts and rescheduling their sleeping time, sleeping aids will likely gain traction in the coming few years.
Sleep Aids are drugs or medical devices that help a person to fall asleep. Improper sleep cycles or sleep disorders have severe effects on one’s work life and health. Sleep Disorders are generally caused by changes in sleeping patterns due to medical issues, psychiatric problems, and environmental issues.
The increased usage of caffeine, tobacco, and alcohol has been causing sleep disorders in the population. This constitutes one of the major factors driving the Asia-Pacific sleep aids market. Further, an increase in demand for sleeping pills due to stressful modern lifestyle and awareness initiative for sleep disorder by various organizations has also contributed to the rapid growth of the Asia-Pacific Sleep Aids market. Apart from these, the sleep aids market also faces some challenges and restraints, including side effects associated with sleeping aids medications and patent expiration of treatment pills for sleep disorders.
This research report on the Asia Pacific Sleep Aids market has been segmented and sub-segmented into the following categories:
By Sleep Disorder:
By Product:
By Medication Type:
By Country:
The Asia-Pacific Sleep Aids market is segmented based on Sleep disorders, Products, and Medication types. Based on sleep disorder, the sleep aids market is segmented under Insomnia, Sleep Apnea, Narcolepsy, Restless legs syndrome, and Sleepwalking. The Asia-Pacific Sleep Aids market is segmented into Sleep Laboratories, Mattresses & Pillows, Medication, and Sleep apnea devices by product. Based on Medication types, the segmentation is done under Prescription-based Drugs, OTC drugs, and Herbal Drugs. Sleep apnea remains to be the fastest-growing segment compared to other sleep disorders. In contrast, Mattresses and pillows are expected to continue leading the Asia-Pacific Sleep Aids market in coming years. Based on medication type, prescription medications hold the largest share in the Sleep Aids market. Based on geographical analysis, the Asia-Pacific Sleep Aids market is segmented under various countries, namely China, India, Japan, Australia, and South Korea.
Some of the major companies dominating the Asia Pacific Sleep Aids market are Pfizer, Cadwell, Merck & Co., Koninklijke Philips N.V. (Philips), Sanofi, Care Fusion Corporation, GlaxoSmithKline Plc, Natus Medical manufactures, SleepMed, and DeVilbiss Healthcare LLC.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Sleep Disorder
5.1.1 Introduction
5.1.2 Insomnia
5.1.3 Sleep Apnea
5.1.4 Restless legs syndrome
5.1.5 Narcolepsy
5.1.6 Sleep Walking
5.1.6 Y-o-Y Growth Analysis, By Sleep Disorder
5.1.7 Market Attractiveness Analysis, By Sleep Disorder
5.1.8 Market Share Analysis, By Sleep Disorder
5.2 Product
5.2.1 Introduction
5.2.2 Mattresses & Pillows
5.2.3 Sleep Laboratories
5.2.4 Medications
5.2.5 Sleep apnea devices
5.2.6 Y-o-Y Growth Analysis, By Product
5.2.7 Market Attractiveness Analysis, By Product
5.2.8 Market Share Analysis, By Product
5.3 Medication
5.3.1 Introduction
5.3.2 Prescription-based Drugs
5.3.3 OTC Drugs
5.3.4 Herbal Drugs
5.3.5 Y-o-Y Growth Analysis, By Medication
5.3.6 Market Attractiveness Analysis, By Medication
5.3.7 Market Share Analysis, By Medication
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Sleep Disorder
6.1.3.3 By Product
6.1.3.4 By Medication
6.1.3.5 By Indication
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Sleep Disorder
6.1.4.3 By Product
6.1.4.4 By Medication
6.1.4.5 By Indication
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Sleep Disorder
6.1.5.3 By Product
6.1.5.4 By Medication
6.1.5.5 By Indication
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Sanofi
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Merck & Co
8.3 Pfizer
8.4 Koninklijke Philips N.V.
8.5 GlaxoSmithKline Plc
8.6 Care Fusion Corporation
8.7 Cadwell
8.8 Sleepmed
8.9 Natus Medical Manufacturers
8.10 DeVilbiss Healthcare LLC
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
